Arcutis Biotherapeutics Inc (ARQT) USD0.0001
2.52%- This stock can be held in a
Stocks and Shares ISASell:$10.34
Buy:$10.36
Change:
$0.33
(3.09%)
$0.33
(3.09%)Prices delayed by at least 15 minutes
Sell:$10.34
Buy:$10.36
Change:$0.33
(3.09%)
$0.33
(3.09%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 1 July 2024 | Howard G WelgusDirector | Sell Option/Award related | 10,000 | $9.31 | $93,141.00 | 180,339 |
| 4 June 2024 | Howard G WelgusDirector | Sell Option/Award related | 3,542 | $8.00 | $28,336.00 | 176,658 |
| 4 June 2024 | Howard G WelgusDirector | Sell Option/Award related | 6,458 | $8.01 | $51,755.70 | 170,200 |
| 30 May 2024 | Patrick BurnettChief Level Officer | Sell Option/Award related | 23,000 | $8.75 | $201,319.00 | 209,793 |
| 29 May 2024 | Patrick BurnettChief Level Officer | Sell Regular sell transaction (market) | 49,952 | $8.72 | $435,386.63 | 209,793 |
| 28 May 2024 | Masaru (Mas) MatsudaCompany Secretary | Sell Tax related | 1,775 | $9.01 | $15,988.14 | 188,508 |
| 17 May 2024 | Larry Todd EdwardsChief Level Officer | Sell Tax related | 7,640 | $8.98 | $68,581.99 | 140,360 |
| 2 May 2024 | Todd Franklin WatanabePresident/CEO | Sell Tax related | 13,783 | $8.74 | $120,433.10 | 860,750 |
| 2 May 2024 | Patrick BurnettChief Level Officer | Sell Tax related | 9,555 | $8.74 | $83,489.68 | 259,745 |
| 2 May 2024 | Masaru (Mas) MatsudaCompany Secretary | Sell Tax related | 5,016 | $8.74 | $43,828.80 | 185,408 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 29 May 2024 | Patrick BurnettChief Level Officer | Sell Regular sell transaction (market) | 49,952 | $8.72 | $435,386.63 | 209,793 |
| 30 May 2024 | Patrick BurnettChief Level Officer | Sell Option/Award related | 23,000 | $8.75 | $201,319.00 | 209,793 |
| 24 October 2023 | FRAZIER LIFE SCIENCES VIII LPVenture Capital | Buy Regular purchase transaction | 80,000 | $2.50 | $200,000.00 | 8,764,232 |
| 4 March 2024 | FRAZIER LIFE SCIENCES VIII LPVenture Capital | Buy Regular purchase transaction | 21,052 | $9.50 | $199,994.00 | 8,785,284 |
| 4 March 2024 | Todd Franklin WatanabePresident/CEO | Sell Option/Award related | 14,903 | $11.12 | $165,739.24 | 874,533 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.